Clear evidence of Revita activity: The study met its 3-month efficacy endpoint with strong statistical significance (p=0.014), delivering 2.5% further weight loss with Revita (n=29) even after stopping tirzepatide, versus 10% weight regain in sham-treated patients (n=16)
Because not a GLP-1 candidate is not the same as nothing can help. Sometimes the evaluation itself is the win
Meet Success by Sesame, Sesames New Weight Loss Program Key takeaways Sesames new weight loss program, Success by Sesame, is priced at just $59 per month with an annual subscription Eligible patients will receive a prescription for brand-name GLP-1s like Wegovy, Zepbound, or another weight loss medication if appropriate (medication cost is not included in the subscription price) The subscription also includes face-to-face video visits with a provider of the patient's choice, unlimited provider messaging, lab work, close clinical supervision & more A truly affordable weight loss program is finally here
SGLT2 inhibitors remain first-line therapies for renal protection in patients with diabetes
While it is authorized, supply levels can vary, and it is subject to the same strict residency and prescription rules as other GLP-1 medications